InsiderClue
Stocks · Health care · Pharmaceutical Preparations

InMed Pharmaceuticals Inc.

INM Clue Score66
British Columbia, Canada Fiscal year ends June CIK 0001728328
$1.36 +2.26% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $1.36 −8.72% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2020Net income−8.9Fiscal year 2021Revenue1.9Operating income−10.2Net income−10.2EPS, diluted−37.96Fiscal year 2022Revenue1.4 −28.3%Operating income−18.6Net income−18.6EPS, diluted−33.17Fiscal year 2023Revenue4.1 +202.8%Operating income−7.9Net income−7.9EPS, diluted−3.25Fiscal year 2024Revenue4.6 +11.2%Net income−7.7EPS, diluted−20.14Fiscal year 2025Revenue4.9 +7.5%Net income−8.2EPS, diluted−8.36Fiscal year 2026Net income−12.6EPS, diluted−3.12
FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Revenue n/a 1.9 1.4 4.1 4.6 4.9 n/a
Growth −28.3% +202.8% +11.2% +7.5%
Operating income n/a −10.2 −18.6 −7.9 n/a n/a n/a
Net income −8.9 −10.2 −18.6 −7.9 −7.7 −8.2 −12.6
Growth
EPS, diluted n/a −37.96 −33.17 −3.25 −20.14 −8.36 −3.12

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2020Fiscal year 2021Operating margin−535.9%Net margin−535.9%Free cash flow margin−514.3%Fiscal year 2022Gross margin39.8%Operating margin−1,361.9%Net margin−1,361.9%Free cash flow margin−1,143.9%Fiscal year 2023Gross margin33.9%Operating margin−192.2%Net margin−192.2%Free cash flow margin−180.0%Fiscal year 2024Gross margin23.9%Net margin−166.9%Free cash flow margin−152.1%Fiscal year 2025Gross margin34.5%Net margin−165.1%Fiscal year 2026
FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Gross margin n/a n/a 39.8% 33.9% 23.9% 34.5% n/a
Operating margin n/a −535.9% −1,361.9% −192.2% n/a n/a n/a
Net margin n/a −535.9% −1,361.9% −192.2% −166.9% −165.1% n/a
Free cash flow margin n/a −514.3% −1,143.9% −180.0% −152.1% n/a n/a

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2020Operating cash flow−7.4Capital expenditure−0.0Free cash flow−7.4Fiscal year 2021Operating cash flow−9.8Capital expenditure−0.0Free cash flow−9.8Fiscal year 2022Operating cash flow−15.6Capital expenditure−0.0Free cash flow−15.6Fiscal year 2023Operating cash flow−7.3Capital expenditure−0.2Free cash flow−7.4Fiscal year 2024Operating cash flow−7.0Capital expenditure−0.0Free cash flow−7.0Fiscal year 2025Operating cash flow−8.1Fiscal year 2026Operating cash flow−8.6
FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Operating cash flow −7.4 −9.8 −15.6 −7.3 −7.0 −8.1 −8.6
Capital expenditure −0.0 −0.0 −0.0 −0.2 −0.0 n/a n/a
Free cash flow −7.4 −9.8 −15.6 −7.4 −7.0 n/a n/a
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2020Cash5.8Shareholders’ equity5.9Fiscal year 2021Cash7.4Shareholders’ equity7.4Fiscal year 2022Cash6.2Shareholders’ equity9.1Fiscal year 2023Cash8.9Shareholders’ equity12.1Fiscal year 2024Cash6.6Shareholders’ equity9.2Fiscal year 2025Cash11.1Shareholders’ equity13.4Fiscal year 2026Cash2.2Shareholders’ equity1.1
FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Cash 5.8 7.4 6.2 8.9 6.6 11.1 2.2
Shareholders’ equity 5.9 7.4 9.1 12.1 9.2 13.4 1.1

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2026 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending June, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2020 30 Jun 2020 FY2021† 30 Jun 2021 FY2022† 30 Jun 2022 FY2023† 30 Jun 2023 FY2024† 30 Jun 2024 FY2025† 30 Jun 2025 FY2026† 30 Jun 2026
Revenue and profit
n/a 1.9 1.4 4.1 4.6 4.9 n/a
Growth −28.3% +202.8% +11.2% +7.5%
n/a n/a 0.5 2.7 3.5 3.2 n/a
n/a n/a 0.5 1.4 1.1 1.7 n/a
Growth +158.1% −21.5% +55.0%
5.8 5.3 7.3 3.7 3.2 2.8 3.0
3.2 4.5 6.9 5.8 5.8 5.4 6.7
n/a −10.2 −18.6 −7.9 n/a n/a n/a
Growth
n/a n/a −18.6 −7.9 −7.7 −8.7 −11.4
n/a n/a n/a 0.0 0.0 n/a n/a
−8.9 −10.2 −18.6 −7.9 −7.7 −8.2 −12.6
Growth
Per share
n/a −37.96 −33.17 −3.25 −20.14 −8.36 −3.12
n/a −37.96 −33.17 −3.25 −20.14 −8.36 −3.12
Growth
n/a 0.3 0.6 2.4 0.4 1.0 4.2
5.2 0.3 0.6 2.4 0.4 1.0 4.2
Growth −94.9% +108.6% +336.6% −84.4% +156.1% +326.6%

† The diluted share count jumps at 2021 and 2022 and 2023 and 2024 and 2025 and 2026, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • A net loss in 7 of 7 years on file.